Sonal Choudhary
Dermatology · Miami, FLNPI 1598064248
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $87,458 of the $98,305 with a category attached, or 89.0%. 11 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 54.8% of the total. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $768.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$54K
- Sanofi$43K
- AbbVie$256
- UCB, Inc.$235
- Galderma Laboratories, L.p.$208
- Novartis$178
- plus $189 from 5 others
Across 4 payments — averaging $2798.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$11K
What the payments were for
- Speaking & faculty fees$87,45889%
- Travel & lodging$7,2647%
- Food & beverage$3,5834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 73 | $53,830 |
| Sanofi | 21 | $43,408 |
| AbbVie | 9 | $256 |
| UCB, Inc. | 4 | $235 |
| Galderma Laboratories, L.p. | 2 | $208 |
| Novartis | 9 | $178 |
| Arcutis Biotherapeutics, Inc. | 4 | $64 |
| Lilly USA, LLC | 3 | $61 |
| Incyte Corporation | 1 | $22 |
| Organon | 1 | $22 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$98,305 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 45 | $446,338 |
| Dupixent SyringeDupilumab | 76 | $293,400 |
| Dupixent PenDupilumab | 66 | $258,321 |
| Tacrolimus | 134 | $16,332 |
| Clobetasol Propionate | 132 | $4,634 |
| Clindamycin Phosphate | 82 | $3,442 |
| Ketoconazole | 153 | $2,506 |
| Triamcinolone Acetonide | 184 | $1,982 |
| Tretinoin | 22 | $1,019 |
| Fluorouracil | 13 | $757 |
| Mometasone Furoate | 25 | $469 |
| Ciclopirox | 27 | $438 |
| Montelukast Sodium | 33 | $391 |
| Spironolactone | 35 | $378 |
| Naltrexone Hcl | 11 | $347 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miami
- Francisco KerdelMiami$2.1M
- Robert KirsnerMiami$1.4M
- Gil YosipovitchMiami$1M
- Mercedes GonzalezMiami$943K
- Heather Woolery LloydMiami$609K
- Hadar Lev-TovMiami$326K
- Lawrence SchachnerMiami$309K
- Giovanna CioccaMiami$222K
- Janice Lima MaribonaMiami$217K
- Jill WaibelMiami$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.